Statement by Zimmer Holdings, Inc.
New York Times Article
July 29, 2008
An article in the July 29, 2008 edition of The New York Times on the need for joint registries to effectively track post-market patient outcomes does not provide sufficient context and data about the life-changing and well documented benefits achieved by millions of hip replacement surgery [...]
Today in an article titled ‘Zimmer Durom Cup Problems Highlight Need for Joint Registry’ the New Yorks time highlighted the recent controversy surround the Zimmer hip implant recall and the need for a national database, called a joint registry.
“Hundreds of patients receiving Zimmer Durom Cup hip implants in the U.S. have been experiencing serious problems [...]
Since we last wrote to you in May 2008 regarding the Durom® Acetabular Component (“Durom Cup”), Zimmer has completed an extensive investigation of clinical experience with this product and its conformance to specifications. We are able at this time to share with you key conclusions and actions with respect to the Durom Cup in the [...]
Zimmer Holdings, Inc (NYSE and SWX: ZMH) is temporarily suspending marketing and distribution of the Durom® Acetabular Component (Durom Cup) in the United States, while the Company updates labeling to provide more detailed surgical technique instructions to surgeons and implements its surgical training program in the U.S. The Durom Cup will continue to be marketed [...]
Please note that there is no attorney- client relationship created until you have signed a retainer agreement and your case has been accepted. Disclaimer